Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Multicenter Study of More Intensive Versus Less Intensive Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia (AML) or Transformed Refractory Anemia With Excess Blasts (RAEB-t).

NCT00363025 is registered in ClinicalTrials.gov with Acute Leukemia French Association as lead sponsor.

NCT NCT00363025
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00363025 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Multicenter Study of More Intensive Versus Less Intensive Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia (AML) or Transformed Refractory Anemia With Excess Blasts (RAEB-t).
Lead sponsor
Acute Leukemia French Association
Phase
Phase 3
Overall status
Terminated
Start date
November 30, 1999
Completion date
April 30, 2006
Enrollment
465
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute myeloid leukemia